Flow cytometry defined cytoplasmic immunoglobulin index is a major prognostic factor for progression of asymptomatic monoclonal gammopathies to multiple myeloma (subset analysis of SWOG S0120)

Blood Cancer J. 2016 Mar 25;6(3):e410. doi: 10.1038/bcj.2016.19.

Authors

X Papanikolaou¹, A Rosenthal², M Dhodapkar³, J Epstein¹, R Khan¹, F van Rhee¹, Y Jethava¹, S Waheed¹, M Zangari¹, A Hoering², J Crowley², D Alapat⁴, F Davies¹, G Morgan¹, B Barlogie¹

Affiliations

¹ Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
² Cancer Research and Biostatistics, Seattle, WA, USA.
³ Yale School of Medicine, New Haven, CT, USA.
⁴ Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Asymptomatic Diseases
Biomarkers, Tumor*
Disease Progression
Flow Cytometry*
Humans
Immunoglobulins / metabolism*
Monoclonal Gammopathy of Undetermined Significance / diagnosis*
Monoclonal Gammopathy of Undetermined Significance / pathology
Multiple Myeloma / diagnosis*
Multiple Myeloma / pathology

Substances

Biomarkers, Tumor
Immunoglobulins

Grants and funding